Apollon Wealth Management, LLC Abbott Laboratories Transaction History

Apollon Wealth Management, LLC

$3.45 Billion
Q3 2024

A detailed history of Apollon Wealth Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Apollon Wealth Management, LLC holds 62,099 shares of ABT stock, worth $7.28 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

62,099

Previous 61,875 0.36%

Holding current value

$7.28 Million

Previous $6.43 Million 10.11%

% of portfolio

0.21%

Previous 0.2%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$100.07 - $118.13 $22,415 - $26,461	224 Added 0.36%	62,099 $7.08 Million
Q2 2024 Jul 19, 2024	BUY	$100.73 - $112.44 $53,487 - $59,705	531 Added 0.87%	61,875 $6.43 Million
Q1 2024 May 02, 2024	SELL	$109.52 - $120.96 $344,549 - $380,540	-3,146 Reduced 4.88%	61,344 $6.97 Million
Q4 2023 Feb 06, 2024	BUY	$90.19 - $110.4 $1.69 Million - $2.07 Million	18,779 Added 41.08%	64,490 $7.1 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $613,971 - $736,662	6,427 Added 16.36%	45,711 $4.43 Million
Q2 2023 Aug 04, 2023	BUY	$100.78 - $112.29 $1.25 Million - $1.39 Million	12,400 Added 46.12%	39,284 $4.28 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $90,176 - $106,143	-931 Reduced 3.35%	26,884 $2.72 Million
Q4 2022 Feb 15, 2023	BUY	$95.06 - $111.52 $96,961 - $113,750	1,020 Added 3.81%	27,815 $3.05 Million
Q3 2022 Nov 08, 2022	BUY	$96.76 - $112.03 $168,846 - $195,492	1,745 Added 6.97%	26,795 $2.59 Million
Q2 2022 Aug 11, 2022	SELL	$102.07 - $123.37 $165,149 - $199,612	-1,618 Reduced 6.07%	25,050 $2.72 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $191,325 - $233,309	-1,678 Reduced 5.92%	26,668 $3.16 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $1.69 Million - $2.07 Million	14,642 Added 106.84%	28,346 $3.99 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $1.09 Million - $1.21 Million	9,339 Added 213.95%	13,704 $1.62 Million
Q2 2021 Aug 12, 2021	SELL	$105.79 - $124.53 $126,101 - $148,439	-1,192 Reduced 21.45%	4,365 $506,000
Q1 2021 May 17, 2021	SELL	$108.84 - $128.23 $5.29 Million - $6.23 Million	-48,603 Reduced 89.74%	5,557 $666,000
Q4 2020 Jan 29, 2021	BUY	$105.0 - $114.42 $5.36 Million - $5.84 Million	51,075 Added 1655.59%	54,160 $5.93 Million
Q3 2020 Nov 03, 2020	BUY	$91.64 - $111.29 $49,210 - $59,762	537 Added 21.08%	3,085 $336,000
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $195,100 - $249,704	2,548 New	2,548 $233,000
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $51,313 - $55,639	-627 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $45,695 - $53,295	627 New	627 $53,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Apollon Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apollon Wealth Management, LLC with notifications on news.

Account

Apollon Wealth Management, LLC Abbott Laboratories Transaction History